Literature DB >> 2445616

Kinetics of carcinoembryonic antigen and carbohydrate antigen 19-9 production in a human pancreatic cancer cell line (SUIT-2).

T Iwamura1, T Katsuki.   

Abstract

Kinetics of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA19-9) production in a human pancreatic cancer cell line (SUIT-2) were investigated. Production of CEA reached a maximum, 31.0 ng/1 X 10(6) cells, in the late stationary phase with transient decline during the early exponential phase and 15.5% of the produced CEA was released into the medium, while production of CA19-9 reached a maximum, 421 U/1 X 10(6) cells, in the early stationary phase and 68.8% of the produced CA19-9 was released into the medium. Accordingly, the kinetics of CEA and CA19-9 production of SUIT-2 in vitro might be independent. CEA was stained immunohistochemically in the cytoplasm of the cells forming small buds above the monolayer cell sheet. On the contrary, CA19-9 positive cells were observed scattered in the monolayer cell sheet and CA19-9 was stained in the cytoplasm, predominantly at the projections of the cell surface. CEA and CA19-9 were also detected in the sera of nude mice bearing SUIT-2 tumors and their concentrations correlated well with tumor volume. Correlation coefficients between tumor markers and tumor volume were 0.79 (p less than 0.01) for CEA and 0.90 (p less than 0.01) for CA19-9.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445616     DOI: 10.1007/bf02776726

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  Production of immunoreactive calcitonin and some other tumor markers by established human carcinoma cell lines.

Authors:  S Ichiki; M Kuroki; A Matsunaga; M Kuroki; Y Matsuoka
Journal:  Jpn J Cancer Res       Date:  1986-03

2.  Establishment and characterization of the human cholangiocarcinoma cell line HChol-Y1 in a serum-free, chemically defined medium.

Authors:  N Yamaguchi; H Morioka; H Ohkura; S Hirohashi; K Kawai
Journal:  J Natl Cancer Inst       Date:  1985-07       Impact factor: 13.506

3.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

4.  Release of monoclonal antibody-defined antigens by human colorectal carcinoma and melanoma cells.

Authors:  Z Steplewski; T H Chang; M Herlyn; H Koprowski
Journal:  Cancer Res       Date:  1981-07       Impact factor: 12.701

5.  Establishment and characterization of human pancreatic adenocarcinoma cell line SW-1990 in tissue culture and the nude mouse.

Authors:  A P Kyriazis; W B McCombs; A A Sandberg; A A Kyriazis; N H Sloane; R Lepera
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

6.  Subcellular distribution, synthesis, and release of carcinoembryonic antigen in cultured human colon adenocarcinoma cell lines.

Authors:  Z R Shi; D Tsao; Y S Kim
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

7.  Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.

Authors:  B C Del Villano; S Brennan; P Brock; C Bucher; V Liu; M McClure; B Rake; S Space; B Westrick; H Schoemaker; V R Zurawski
Journal:  Clin Chem       Date:  1983-03       Impact factor: 8.327

8.  Carcinoembryonic antigen production in human gastric cancer cell lines in vitro and in nude mice.

Authors:  T Motoyama; H Watanabe
Journal:  Gan       Date:  1983-10

9.  Observations on the synthesis of carcinoembryonic antigen by an established human colonic carcinoma cell line.

Authors:  B Drewinko; L Y Yang
Journal:  Oncology       Date:  1980       Impact factor: 2.935

10.  Establishment and characterization of human colorectal cancer cell lines.

Authors:  J A McBain; J L Weese; L F Meisner; W H Wolberg; J K Willson
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

View more
  2 in total

1.  High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice.

Authors:  N Kitamura; T Iwamura; S Taniguchi; H Yamanari; M A Kawano; K Hollingsworth; T Setoguchi
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

2.  Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.

Authors:  Jacob L Houghton; Brian M Zeglis; Dalya Abdel-Atti; Robert Aggeler; Ritsuko Sawada; Brian J Agnew; Wolfgang W Scholz; Jason S Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-14       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.